Generally speaking, the more specific a drug is for its target, the fewer unwanted side-effects there are. There is huge potential of (what’s known as) monoclonal antibody therapy, pharmacologist Roger McFadden argues.
This kind of therapy may provide the magic bullet that will enable us to tackle currently intractable diseases because of its highly targeted potency.
Roger McFadden, author of Introducing Pharmacology: For nursing and healthcare, was a Senior Lecturer in Pharmacology in the Faculty of Health at Birmingham City University at the time of writing his contribution to The New Optimists.
He has since retired and is writing another book on pharmacology.